Orange Juice Helps Boost Blood Levels of AIDS Drug

July 07, 1996

Orange Juice Helps Boost Blood Levels of AIDS Drug</HTML>
Embargoed Until: July 8, 4 p.m.

Contact: Ellen Goldbaum
Contact phone: 716-645-2626
Contact fax: 716-645-3765
Contact email: goldbaum@newsb.buffalo.edu

ORANGE JUICE HELPS BOOST BLOOD LEVELS OF AIDS DRUG

VANCOUVER -- A glass of orange juice appears to enhance the effect of a potent experimental AIDS drug, according to research in the Laboratory for Antiviral Research in the University at Buffalo School of Pharmacy.

Too little stomach acid, a complication of AIDS, can interfere with the absorption of delavirdine, a promising new AIDS drug developed by Upjohn, which is close to filing a New Drug Application for the drug with the U.S. Food and Drug Administration.

The UB researchers found that a glass of orange juice boosts the level of stomach acid and, in turn, the level of the drug in the blood of those receiving the medication, Gene Morse, Pharm.D., reported here today (July 8, 1996) at the International AIDS Conference.

The work was done by Morse, associate professor, chair of the Department of Pharmacy Practice at UB and director of the Laboratory for Antiviral Research; Mark Shelton, Pharm.D., UB research assistant professor, and Ross Hewitt, M.D., director of immunodeficiency services at the Erie County Medical Center. It was funded by the National Institutes of Health and Upjohn Pharmaceuticals.

Morse explained that the researchers targeted certain concentrations of delavirdine in patients and studied the factors that prevented achieving those targets. They found that large changes in blood levels of delavirdine can result from very small changes in absorption.

"If patients have reduced stomach acid, they may absorb less drug and may not receive adequate therapeutic benefit," he added.

In the study, 20 patients swallowed a consumable, radiotelemetry device that, upon reaching the stomach, sent a signal to a computer that recorded their gastric-acid levels.

Patients with low levels were given orange juice or glutamic acid along with delavirdine.

"Both were effective in boosting acid and drug levels to the point where the expected therapeutic benefit should be achieved," Morse noted.

Back to News Release Summaries


University at Buffalo

Related Aids Articles from Brightsurf:

Developing a new vaccination strategy against AIDS
Infection researchers from the German Primate Center (DPZ) -- Leibniz Institute for Primate Research have in cooperation with international colleagues tested a new vaccination strategy against the HIV-related simian immunodeficiency virus (SIV) in rhesus monkeys.

HIV-AIDS: Following your gut
Researchers find a way to reduce replication of the AIDS virus in the gastrointestinal tract.

A path toward ending AIDS in the US by 2025
Using prevention surveillance data to model rates of HIV incidence, prevalence and mortality, investigators at Brigham and Women's Hospital and Johns Hopkins Bloomberg School of Public Health set targets, specifically a decrease in new infections to 21,000 by 2020 and to 12,000 by 2025, that would mark a transition toward ending the HIV/AIDS epidemic.

What does it take for an AIDS virus to infect a person?
Researchers examined the characteristics of HIV-1 strains that were successful in traversing the genital mucosa that forms a boundary to entry by viruses and bacteria.

How AIDS conquered North America
A new technique that allowed researchers to analyze genetic material from serum samples of HIV patients taken before AIDS was known provides a glimpse of unprecedented detail into the beginnings of the AIDS epidemic in North America.

New research could help build better hearing aids
Scientists at Binghamton University, State University of New York want to improve sensor technology critical to billions of devices made every year.

NY State Department of Health AIDS Institute funds HIV/AIDS prevention in high-risk youth
NewYork-Presbyterian's Comprehensive Health Program and Project STAY, an initiative of the Harlem Heath Promotion Center (HHPC) at Columbia University's Mailman School of Public Health has received two grants totaling more than $3.75 million from the New York State Department of Health AIDS Institute for their continued efforts to prevent HIV/AIDS in at-risk youth.

A new way to nip AIDS in the bud
When new HIV particles bud from an infected cell, the enzyme protease activates to help the viruses infect more cells.

AIDS research prize for Warwick academic
A researcher at the University of Warwick has received international recognition for his contribution to AIDS research.

Insects inspire next generation of hearing aids
An insect-inspired microphone that can tackle the problem of locating sounds and eliminate background noise is set to revolutionize modern-day hearing aid systems.

Read More: Aids News and Aids Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.